Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Galicaftor

Copy Product Info
😃Good
Catalog No. T22252Cas No. 1918143-53-9
Alias GLPG-2222, GLPG2222, ABBV-2222, ABBV2222

Galicaftor (ABBV-2222; GLPG-2222) is a potent and orally active cystic fibrosis transmembrane conductance regulator (CFTR) corrector that enhances CFTR protein folding and trafficking, Galicaftor is widely used in cystic fibrosis research to study CFTR rescue mechanisms, epithelial ion transport, and therapeutic correction of underlying molecular defects.

Galicaftor

Galicaftor

Copy Product Info
😃Good
Purity: 98.84%
Catalog No. T22252Alias GLPG-2222, GLPG2222, ABBV-2222, ABBV2222Cas No. 1918143-53-9
Galicaftor (ABBV-2222; GLPG-2222) is a potent and orally active cystic fibrosis transmembrane conductance regulator (CFTR) corrector that enhances CFTR protein folding and trafficking, Galicaftor is widely used in cystic fibrosis research to study CFTR rescue mechanisms, epithelial ion transport, and therapeutic correction of underlying molecular defects.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$88-In Stock
5 mg$213-In Stock
10 mg$347-In Stock
25 mg$695-In Stock
50 mg$1,090-In Stock
100 mg$1,820-In Stock
1 mL x 10 mM (in DMSO)$263-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.84%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Galicaftor (ABBV-2222; GLPG-2222) is a potent and orally active cystic fibrosis transmembrane conductance regulator (CFTR) corrector that enhances CFTR protein folding and trafficking, Galicaftor is widely used in cystic fibrosis research to study CFTR rescue mechanisms, epithelial ion transport, and therapeutic correction of underlying molecular defects.
Targets&IC50
Cl- channel:< 10 nM (EC50)
In vitro
In cellular assays using primary patient cells homozygous for the F508del/F508del mutation, Galicaftor demonstrates functional restoration of chloride channel activity with an EC₅₀ of < 10 nM [2].
In vivo
In pharmacokinetic studies conducted in rats, Galicaftor has been evaluated for its physiological properties. Following intravenous (i.v.) administration at a dose of 1 mg/kg, the observed half-life (T1/2) is approximately 2.7 h. When administered via the intragastric (oral) route at 1 mg/kg, the molecule exhibits absorption with an oral bioavailability (%F) of 74%. These parameters support the investigation of the molecule in oral dosing regimens within preclinical animal models [1].
SynonymsGLPG-2222, GLPG2222, ABBV-2222, ABBV2222
Chemical Properties
Molecular Weight559.46
FormulaC28H21F4NO7
Cas No.1918143-53-9
SmilesC(N[C@H]1C=2C(O[C@H](C1)C3=CC=C(C(O)=O)C=C3)=CC(OC(F)F)=CC2)(=O)C4(CC4)C=5C=C6C(=CC5)OC(F)(F)O6
Relative Density.1.56 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (143 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7874 mL8.9372 mL17.8744 mL89.3719 mL
5 mM0.3575 mL1.7874 mL3.5749 mL17.8744 mL
10 mM0.1787 mL0.8937 mL1.7874 mL8.9372 mL
20 mM0.0894 mL0.4469 mL0.8937 mL4.4686 mL
50 mM0.0357 mL0.1787 mL0.3575 mL1.7874 mL
100 mM0.0179 mL0.0894 mL0.1787 mL0.8937 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Galicaftor | purchase Galicaftor | Galicaftor cost | order Galicaftor | Galicaftor chemical structure | Galicaftor in vivo | Galicaftor in vitro | Galicaftor formula | Galicaftor molecular weight